Yeongjin Pharmaceutical has newly appeared among the top searched stocks.


As of 10:30 AM on the 2nd, Yeongjin Pharmaceutical is trading at 7,860 KRW, up 3.01% from the previous day. This represents a 30.78% increase compared to August 18. Yeongjin Pharmaceutical is known as a specialty pharmaceutical company under the KT&G group focusing on prescription drugs.

Today, foreigners have sold a net 11,000 shares of Yeongjin Pharmaceutical, while institutions have bought a net 37,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 273,079 shares, while foreigners and institutions have sold a net 698,199 shares and bought a net 508,339 shares, respectively.


On September 1, Yeongjin Pharmaceutical became a market issue with a 17% increase following news of its affiliate conducting a global clinical trial for a COVID-19 vaccine.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing